OPTICAL FIBER FOR RAMAN AMPLIFICATION

Details for Australian Patent Application No. 2002331351 (hide)

Owner PIRELLI AND C. S.P.A

Inventors TASSONE, Francesco, Maria; DAI, Guojun

Pub. Number AU-A-2002331351

PCT Number PCT/EP02/08383

PCT Pub. Number WO2004/015828

Filing date 26 July 2002

Wipo publication date 25 February 2004

International Classifications

H01S 003/30 Lasers, i.e. devices for generation, amplification, modulation, demodulation, or frequency-changing, using stimulated emission, of infra-red, visible, or ultra-violet waves - using scattering effects, e.g. stimulated Brillouin or Raman effects

H01S 003/17 Lasers, i.e. devices for generation, amplification, modulation, demodulation, or frequency-changing, using stimulated emission, of infra-red, visible, or ultra-violet waves - amorphous, e.g. glass

C03C 004/00 Compositions for glass with special properties

C03C 003/12 Glass compositions - Silica-free oxide glass compositions

Event Publications

6 February 2003 Complete Application Filed

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2002331351

14 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002331352-TRANSDERMAL THERAPEUTIC SYSTEM (RESERVOIR-TTS) FOR USING PRAMIPEXOLE AND ROPINIROLE

2002331350-Use of biologically active HIV-1 Tat, fragments or derivatives thereof, to target and/or to activate antigenpresenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases